Literature DB >> 22043064

The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations.

Félix Vargas1, Isabel Rodríguez-Gómez, Pablo Vargas-Tendero, Eugenio Jimenez, Mercedes Montiel.   

Abstract

Thyroid disorders are among the most common endocrine diseases and affect virtually all physiological systems, with an especially marked impact on cardiovascular and renal systems. This review summarizes the effects of thyroid hormones on the renin-angiotensin system (RAS) and the participation of the RAS in the cardiovascular and renal manifestations of thyroid disorders. Thyroid hormones are important regulators of cardiac and renal mass, vascular function, renal sodium handling, and consequently blood pressure (BP). The RAS acts globally to control cardiovascular and renal functions, while RAS components act systemically and locally in individual organs. Various authors have implicated the systemic and local RAS in the mediation of functional and structural changes in cardiovascular and renal tissues due to abnormal thyroid hormone levels. This review analyzes the influence of thyroid hormones on RAS components and discusses the role of the RAS in BP, cardiac mass, vascular function, and renal abnormalities in thyroid disorders.

Entities:  

Mesh:

Year:  2011        PMID: 22043064     DOI: 10.1530/JOE-11-0349

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  24 in total

Review 1.  The correct renal function evaluation in patients with thyroid dysfunction.

Authors:  Mariadelina Simeoni; Annamaria Cerantonio; Ida Pastore; Rossella Liguori; Marta Greco; Daniela Foti; Elio Gulletta; Antonio Brunetti; Giorgio Fuiano
Journal:  J Endocrinol Invest       Date:  2015-10-28       Impact factor: 4.256

2.  AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.

Authors:  Ana Paula Cremasco Takano; Nathalia Senger; Carolina Demarchi Munhoz; Maria Luiza Morais Barreto-Chaves
Journal:  Pflugers Arch       Date:  2017-11-25       Impact factor: 3.657

Review 3.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

Review 4.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

5.  Expression of Circulating Rennin-Angiotensin-Aldosterone-Related microRNAs in Patients with Thyrotoxic Heart Disease.

Authors:  H M Li; Y X Chen; X M Fan; L L Chen
Journal:  Bull Exp Biol Med       Date:  2021-12-02       Impact factor: 0.804

6.  Novel cell-based assay for detection of thyroid receptor beta-interacting environmental contaminants.

Authors:  Diana A Stavreva; Lyuba Varticovski; Ludmila Levkova; Anuja A George; Luke Davis; Gianluca Pegoraro; Vicki Blazer; Luke Iwanowicz; Gordon L Hager
Journal:  Toxicology       Date:  2016-08-12       Impact factor: 4.221

Review 7.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

8.  L-Arginine metabolism in cardiovascular and renal tissue from hyper- and hypothyroid rats.

Authors:  Isabel Rodríguez-Gómez; Juan N Moliz; Andrés Quesada; Sebastian Montoro-Molina; Pablo Vargas-Tendero; Antonio Osuna; Rosemary Wangensteen; Félix Vargas
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-15

Review 9.  The Interplay Between Thyroid Dysfunction and Kidney Disease.

Authors:  Yoko Narasaki; Peter Sohn; Connie M Rhee
Journal:  Semin Nephrol       Date:  2021-03       Impact factor: 5.299

10.  Treatment of hypothyroidism improves glomerular filtration rate (GFR) in geriatric patients

Authors:  Mert Eşme; Oktay Bulur; Mehmet Can Atak; Cafer Balcı; Kürşat Dal; Derun Taner Ertuğrul; Zeliha Günnur Dikmen; Meltem Gülhan Halil; Mustafa Cankurtaran; Burcu Balam Doğu
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.